Cargando…

SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis

Facilitative glucose transporters (GLUTs), which are encoded by solute carrier 2A (SLC2A) genes, are responsible for mediating glucose absorption. In order to meet their higher energy demands, cancer cells are more likely than normal tissue cells to have elevated glucose transporters. Multiple patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanli, Qin, Han, Bian, Jing, Ma, Zhanchuan, Yi, Huanfa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742449/ https://www.ncbi.nlm.nih.gov/pubmed/36518662 http://dx.doi.org/10.3389/fphar.2022.1045179

Ejemplares similares

Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
por: Zhang, Wentao, et al.
Publicado: (2022)

Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer
por: Zhang, Chen, et al.
Publicado: (2023)

Long Noncoding RNAs as Orchestrators of CD4(+) T-Cell Fate
por: Liu, Chang, et al.
Publicado: (2022)

Prediction of Targets of Curculigoside A in Osteoporosis and Rheumatoid Arthritis Using Network Pharmacology and Experimental Verification
por: Han, Jiawen, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice
por: Ma, Zhanchuan, et al.
Publicado: (2020)

Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients
por: Meng, Mei, et al.
Publicado: (2023)

Regulation of DNA‐PK activity promotes the progression of TNBC via enhancing the immunosuppressive function of myeloid‐derived suppressor cells
por: Han, Jiawen, et al.
Publicado: (2022)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
por: Hu, Cong, et al.
Publicado: (2020)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
por: Shen, Zhenghai, et al.
Publicado: (2022)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
por: Balázs, Anita, et al.
Publicado: (2018)

Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
por: Yang, Yuanming, et al.
Publicado: (2022)

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
por: Angelucci, Francesco, et al.
Publicado: (2019)

Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis
por: Lai, Yanni, et al.
Publicado: (2021)

Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets
por: Wang, Shanglin, et al.
Publicado: (2022)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target
por: Xu, Mingming, et al.
Publicado: (2023)

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
por: Li, Yixin, et al.
Publicado: (2022)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
por: Fu, Linhai, et al.
Publicado: (2020)

Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation
por: Liu, Tao, et al.
Publicado: (2022)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 Therapeutics
por: Teodori, Laura, et al.
Publicado: (2020)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022)

Exploring the Mechanism of Flavonoids Through Systematic Bioinformatics Analysis
por: Qiu, Tianyi, et al.
Publicado: (2018)

Establishment and validation of individualized clinical prognostic markers for LUAD patients based on autophagy-related genes
por: Fei, Yuchang, et al.
Publicado: (2022)

Toward a Systematic Structural and Functional Annotation of Solute Carriers Transporters—Example of the SLC6 and SLC7 Families
por: Colas, Claire
Publicado: (2020)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
por: Zhou, Tao-tao, et al.
Publicado: (2023)

Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters
por: Grube, Markus, et al.
Publicado: (2018)

Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
por: Siraj, Abdul K., et al.
Publicado: (2020)

Pan-cancer landscape of CENPO and its underlying mechanism in LUAD
por: Shi, Tongdong, et al.
Publicado: (2023)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
por: Li, Yadong, et al.
Publicado: (2023)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
por: Feng, Hai-Ming, et al.
Publicado: (2023)

Exosomes: potential diagnostic markers and drug carriers for adenomyosis
por: Cheng, Wen-Xiu, et al.
Publicado: (2023)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Targeting ferroptosis as novel therapeutic approaches for epilepsy
por: Jin, Yuzi, et al.
Publicado: (2023)

PPARα: A potential therapeutic target of cholestasis
por: Ye, Xiaoyin, et al.
Publicado: (2022)

TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy
por: Xu, Zhanyu, et al.
Publicado: (2023)

Editorial: New Technologies in Cancer Diagnostics and Therapeutics
por: Li, Haichang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a2597mu4ttnsnrchm1v61h5rhm